Department of Chemistry, Abant İzzet Baysal University, TR-14280 Bolu, Turkey.
Eur J Med Chem. 2012 Feb;48:296-304. doi: 10.1016/j.ejmech.2011.12.028. Epub 2011 Dec 27.
1,2,4-Oxadiazole and 1,2,3-triazole containing heterocyclic compounds continue to gain interest in synthesis of chemical entities and exhibit various biological activities as anti-protozoal and anti-cancer agents. By using the principle of bioisosterism, a series of novel oxadiazolyl pyrrolo triazole diones; namely, (3aS,6aR)-1-((3-(4-substituted phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5-phenyl-1,6a-dihydropyrrolo[3,4-d][1,2,3] triazole-4,6(3aH,5H)-diones (5a-k) was designed and synthesized by the 1,3-dipolar cycloaddition reaction of novel 5-azidomethyl 3-aryl substituted 1,2,4-oxadiazoles (4a-k) with N-phenyl maleimide. The structures of all the cycloadducts were elucidated by means of spectroscopic methods and physical characteristics. The in vitro anti-protozoal and cytotoxic activities of these novel heterocyclic compounds were investigated.
含 1,2,4-恶二唑和 1,2,3-三唑的杂环化合物继续在化学实体的合成中引起关注,并表现出各种生物活性,如抗原生动物和抗癌剂。通过使用生物等排原理,设计并合成了一系列新型的恶二唑基吡咯并三唑二酮;即(3aS,6aR)-1-((3-(4-取代苯基)-1,2,4-恶二唑-5-基)甲基)-5-苯基-1,6a-二氢吡咯并[3,4-d][1,2,3]三唑-4,6(3aH,5H)-二酮(5a-k),通过新型 5-叠氮甲基 3-芳基取代的 1,2,4-恶二唑(4a-k)与 N-苯基马来酰亚胺的 1,3-偶极环加成反应得到。所有环加成物的结构均通过光谱方法和物理特性阐明。研究了这些新型杂环化合物的体外抗原生动物和细胞毒性活性。